Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Formosa Laboratories Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

24 Sep 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Formosa Laboratories Inc (4746-TW)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

29 Sep 2016 Thomson Reuters Stock Report 11 $25.00

Formosa Laboratories, Inc. (4746) - Financial Analysis Review

Formosa Laboratories, Inc. (4746) - Financial Analysis Review Summary Formosa Laboratories, Inc. (Formosa) is a pharmaceutica...

12 Sep 2016 GlobalData 34 $300.00

Wright Investors Service Comprehensive Report for Formosa Laboratories, Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

09 Sep 2016 Wright Reports 65 $75.00

Is Formosa Laboratories, Inc. a Good Long-Term Investment?

02 Sep 2016 Sadif Analytics Prime 12 $25.00

Formosa Laboratories (4746 TT): Profit to Grow Quarter by Quarter

We estimate Formosa’s FY16 sales at NT$3.3bn, +27% YoY, and revise up FY16 GM from 37.5% to 39.9% given that the sales percen...

25 Aug 2016 MasterLink Securities Corporation 6 $58.00

台耀 (4746):新產能已開出,2H16產品組合佳,獲利逐季成長

預估2016年營收33億元,YOY +27%,毛利率部分,從37.5%上修至39.9%,因高毛利率的膽固醇磷酸鹽佔比從27%大幅增加至37%,且2016年膽固醇/磷酸鹽毛利率上升約7~10%,由於2016年台耀產品組合與出貨區域皆優於預期,我們亦將E...

21 Aug 2016 MasterLink Securities Corporation 5 $35.00

Formosa Laboratories, Inc.: Upgraded to Average

05 Aug 2016 Sadif Analytics Prime 3 $10.00

Formosa Laboratories, Inc. (4746) - Financial Analysis Review

Formosa Laboratories, Inc. (4746) - Financial Analysis Review Summary Formosa Laboratories, Inc. (Formosa) is a pharmaceutica...

16 Jun 2016 GlobalData 34 $300.00

Formosa Laboratories (4746 TT); Favorable Product Mix with Sharp Margin Growth

We estimate Formosa’s FY16 sales at NT$3.2bn (up 23% YoY) thanks to pull-in orders from API of Colesevelam and Sevelamer. We ...

06 Jun 2016 MasterLink Securities Corporation 6 $58.00